News

Forma Therapeutics, a biopharmaceutical company, and the Experimental Therapeutics Centre of Singapore, have signed a collaboration agreement to leverage Forma’s transformative chemistry platform to discover novel compounds for

On March 3, SOCMA members and staff met with key EPA staff in North Carolina to discuss the chemical manufacturing area sources proposed rule. The meeting concluded with

The growth and development of nanotechnology now includes a broad range of companies engaged in the production and use of nanoscale materials. Nanotech startups and other companies associated

Nobilon, the human vaccine business unit of Schering-Plough, has initiated its first-in-human clinical development program for SCH 900795, a new intranasal live attenuated influenza vaccine for annual seasonal

Takeda Pharmaceutical Company has launched Ecard, a fixed dose combination tablet of Blopress and a low-dose diuretic for treatment of hypertension. According to Takeda, Ecard is a fixed

YM BioSciences, an oncology product development company, has enrolled the first patient into its multinational trial of nimotuzumab for the treatment of patients with non-small-cell lung cancer. This

NeoMatrix, a medical device company, has completed its C2 funding round totaling $15m. This figure is, due to overwhelming investor demand, 50% more than the company’s initial target

Repros Therapeutics, a developer of oral small molecule drugs, has reported net loss of $5.86m or $0.39 per share, for the three-month period ended December 31, 2008, compared

Synta Pharmaceuticals, a biopharmaceutical company, has reduced its workforce by approximately 90 positions, to a total of approximately 130 positions, allowing the company to operate with current cash